Assessment of dabigatran plasma concentration may improve the safety of anticoagulation in patients treated with ibrutinib with concomitant atrial fibrillation.

Lewicka, Ewa; Daniluk, Paulina; Lasocka, Zofia; Zarzycka, Ewa; Dabrowska-Kugacka, Alicja; Nabialek-Trojanowska, Izabela; Zaucha, Jan M

Lewicka, Ewa; Daniluk, Paulina; Lasocka, Zofia; Zarzycka, Ewa; Dabrowska-Kugacka, Alicja; Nabialek-Trojanowska, Izabela; Zaucha, Jan M.

Afiliación

Lewicka E; Department of Cardiology and Electrotherapy, Medical University of Gdansk, Gdansk, Poland. ewa.lewicka@gumed.edu.pl
Daniluk P; Department of Cardiology and Electrotherapy, Medical University of Gdansk, Gdansk, Poland
Lasocka Z; Department of Cardiology and Electrotherapy, Medical University of Gdansk, Gdansk, Poland
Zarzycka E; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
Dabrowska-Kugacka A; Department of Cardiology and Electrotherapy, Medical University of Gdansk, Gdansk, Poland
Nabialek-Trojanowska I; Department of Cardiology and Electrotherapy, Medical University of Gdansk, Gdansk, Poland
Zaucha JM; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland

Kardiol Pol ; 78(5): 454-457, 2020 05 25.

Article en En | MEDLINE | ID: mdl-32210217

Asunto(s)

Fibrilación Atrial; Adenina/análogos & derivados; Anticoagulantes/efectos adversos; Fibrilación Atrial/complicaciones; Fibrilación Atrial/tratamiento farmacológico; Dabigatrán/efectos adversos; Humanos; Piperidinas; Plasma; Accidente Cerebrovascular; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial Límite: Humans Idioma: En Revista: Kardiol Pol Año: 2020 Tipo del documento: Article País de afiliación: Polonia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google